ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Specialist

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

14,950Medicare Part D Prescriptions Filled, Including Refills

Rank: 8 out of 609

$944K Total Retail Price of All Prescriptions

Rank: 24 out of 609

603 Patients Receiving at Least One Drug in Part D
94%Patients 65 Years and Older
52% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in New Jersey
Lower avg

Schedule Two
Controlled Substances

11% of this provider’s 603 patients filled at least one prescription for a schedule two drug, compared to an average of 8%.

Schedule Three
Controlled Substances

3% of this provider’s 603 patients filled at least one prescription for a schedule three drug, compared to an average of 4%.

Risky Drugs to Seniors

2% of this provider’s 14,160 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

28% of this provider’s prescriptions were for brand-name drugs, compared to an average of 36%.

Prescription Price

$63 was the average price of a prescription from this provider, compared to $117 among peers.

Prescriptions per Patient

25 is the average number of prescriptions (including refills) per patient, compared to an average of 9.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in New Jersey
OMEPRAZOLE 579 571 1 3
SIMVASTATIN 566 555 2 1
LEVOTHYROXINE SODIUM 532 511 3 7
FUROSEMIDE 475 465 4 4
WARFARIN SODIUM 473 457 5 8
AMLODIPINE BESYLATE 382 364 6 2
LISINOPRIL 336 319 7 12
MIRTAZAPINE 268 266 8 58
DONEPEZIL HCL 259 257 9 22
METOPROLOL SUCCINATE 258 250 10 5
POTASSIUM CHLORIDE 253 250 11 40
ATENOLOL 244 243 12 27
ZOLPIDEM TARTRATE 224 205 13 18
OXYCODONE-ACETAMINOPHEN 207 206 S2 14 44
ATORVASTATIN CALCIUM 189 181 15 6
METOPROLOL TARTRATE 183 180 16 9
LACTULOSE 182 143 17 109
NAMENDA 173 171 18 36
ESCITALOPRAM OXALATE 167 165 19 91
IPRATROPIUM-ALBUTEROL 159 159 20 173
METFORMIN HCL 159 137 20 10
DIOVAN 153 150 22 15
HYDROCHLOROTHIAZIDE 143 138 23 20
ALENDRONATE SODIUM 127 122 24 54
ALBUTEROL SULFATE 119 119 25 201
GABAPENTIN 119 91 25 21
LOSARTAN POTASSIUM 119 115 25 24
LISINOPRIL-HYDROCHLOROTHIAZIDE 117 113 28 77
ADVAIR DISKUS 113 112 29 28
GLYBURIDE 112 108 R 30 132
LATANOPROST 112 112 30 19
TRAMADOL HCL 109 109 32 39
PREDNISONE 105 102 33 26
TRIAMTERENE-HCTZ 105 100 33 204
DIGOXIN 103 98 35 33
SERTRALINE HCL 98 96 36 61
OXYCODONE HCL 97 64 S2 37 23
CITALOPRAM HBR 93 92 38 112
BISOPROLOL FUMARATE 92 92 39 228
FAMOTIDINE 88 88 40 50
JANUVIA 87 80 41 34
FENTANYL 86 86 S2 42 66
PANTOPRAZOLE SODIUM 83 74 43 29
CLOPIDOGREL 83 80 43 17
LIPITOR 82 82 45 47
LOSARTAN-HYDROCHLOROTHIAZIDE 79 71 46 69
DOXAZOSIN MESYLATE 77 77 47 129
LEVOFLOXACIN 75 73 48 127
PLAVIX 71 67 49 25
ENALAPRIL MALEATE 71 71 49 32
LYRICA 70 70 51 90
DIVALPROEX SODIUM 70 70 51 101
AZITHROMYCIN 69 68 53 67
SINGULAIR 67 67 54 78
ABILIFY 66 66 55 161
KETOCONAZOLE 65 63 56 118
CARVEDILOL 64 56 57 14
FLUTICASONE PROPIONATE 63 62 58 52
PAROXETINE HCL 63 41 58 123
TAMSULOSIN HCL 63 63 58 11
CELEBREX 59 52 61 60
DILTIAZEM 24HR CD 59 57 61 154
NEXIUM 58 50 63 13
NASONEX 57 57 64 149
RESTASIS 57 39 64 41
CYMBALTA 56 56 66 76
SPIRIVA 54 52 67 43
PRAVASTATIN SODIUM 54 54 67 35
CARBIDOPA-LEVODOPA 54 54 67 49
IPRATROPIUM BROMIDE 53 53 70 227
MEGESTROL ACETATE 53 53 R 70 243
LEVETIRACETAM 52 52 72 70
NITROFURANTOIN MONO-MACRO 51 47 73 131
LIDODERM 51 50 73 81
TRAZODONE HCL 50 49 75 113
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Sept. 14, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.